Barry Clements

1.3k total citations
22 papers, 625 citations indexed

About

Barry Clements is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Epidemiology. According to data from OpenAlex, Barry Clements has authored 22 papers receiving a total of 625 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Pulmonary and Respiratory Medicine, 6 papers in Surgery and 5 papers in Epidemiology. Recurrent topics in Barry Clements's work include Cystic Fibrosis Research Advances (7 papers), Neonatal Respiratory Health Research (5 papers) and Tracheal and airway disorders (5 papers). Barry Clements is often cited by papers focused on Cystic Fibrosis Research Advances (7 papers), Neonatal Respiratory Health Research (5 papers) and Tracheal and airway disorders (5 papers). Barry Clements collaborates with scholars based in Australia, United Kingdom and United States. Barry Clements's co-authors include John O. Warner, John Massie, J O Warner, Stephen M. Stick, Peter D. Sly, S. Brennan, Catherine Gangell, Tonia Douglas, Stan B. Sidhu and T F Lioe and has published in prestigious journals such as American Journal of Respiratory and Critical Care Medicine, European Respiratory Journal and Thorax.

In The Last Decade

Barry Clements

20 papers receiving 595 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Barry Clements Australia 13 417 291 88 56 55 22 625
R. Nové-Josserand France 14 330 0.8× 94 0.3× 113 1.3× 16 0.3× 19 0.3× 34 602
Adèle Coriati Canada 14 459 1.1× 228 0.8× 25 0.3× 45 0.8× 67 1.2× 39 677
M X Fitzgerald Ireland 12 256 0.6× 103 0.4× 83 0.9× 24 0.4× 29 0.5× 23 406
Deok Soo Kim South Korea 11 78 0.2× 57 0.2× 108 1.2× 32 0.6× 33 0.6× 33 341
Marcia Katz United States 5 446 1.1× 140 0.5× 58 0.7× 58 1.0× 58 1.1× 8 564
Claudio Castaños Argentina 10 217 0.5× 129 0.4× 49 0.6× 24 0.4× 7 0.1× 33 354
Michael S. Stalvey United States 14 451 1.1× 126 0.4× 36 0.4× 47 0.8× 98 1.8× 34 743
Arthur S. Tucker United States 11 315 0.8× 113 0.4× 37 0.4× 44 0.8× 22 0.4× 25 485
Rachel Gingold‐Belfer Israel 14 126 0.3× 313 1.1× 69 0.8× 42 0.8× 10 0.2× 61 549
Shih-Ming Chu Taiwan 13 59 0.1× 227 0.8× 65 0.7× 24 0.4× 12 0.2× 21 400

Countries citing papers authored by Barry Clements

Since Specialization
Citations

This map shows the geographic impact of Barry Clements's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barry Clements with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barry Clements more than expected).

Fields of papers citing papers by Barry Clements

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barry Clements. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barry Clements. The network helps show where Barry Clements may publish in the future.

Co-authorship network of co-authors of Barry Clements

This figure shows the co-authorship network connecting the top 25 collaborators of Barry Clements. A scholar is included among the top collaborators of Barry Clements based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barry Clements. Barry Clements is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Durieu, I., Barry Clements, Benedetta Fabrizzi, et al.. (2025). Impact of Elexacaftor/Tezacaftor/Ivacaftor on Glucose Tolerance and Abnormal Glucose Metabolism: A Phase 3b, Open-Label Clinical Trial. American Journal of Respiratory and Critical Care Medicine. 211(10). 1926–1934. 1 indexed citations
2.
Ditcham, William, et al.. (2024). Jet versus vibrating mesh nebulizer for tobramycin aerosol in spontaneously breathing children with tracheostomies: A simulation study. Anaesthesia Critical Care & Pain Medicine. 44(1). 101455–101455. 1 indexed citations
3.
Hancock, David G., Naomi M. Scott, Kyle T. Mincham, et al.. (2024). Treatment with inhaled aerosolised ethanol reduces viral load and potentiates macrophage responses in an established influenza mouse model. Experimental Lung Research. 50(1). 118–126.
4.
Hancock, David G., William Ditcham, Yuliya V. Karpievitch, et al.. (2024). A phase I clinical trial assessing the safety, tolerability, and pharmacokinetics of inhaled ethanol in humans as a potential treatment for respiratory tract infections. Frontiers in Medicine. 11. 1324686–1324686. 2 indexed citations
5.
Stick, Stephen M., Robert S. Ware, Harm A.W.M. Tiddens, et al.. (2022). The effect of azithromycin on structural lung disease in infants with cystic fibrosis (COMBAT CF): a phase 3, randomised, double-blind, placebo-controlled clinical trial. The Lancet Respiratory Medicine. 10(8). 776–784. 20 indexed citations
6.
Garratt, Luke W., Oded Breuer, Daniel R. Laucirica, et al.. (2021). Changes in airway inflammation with pseudomonas eradication in early cystic fibrosis. Journal of Cystic Fibrosis. 20(6). 941–948. 15 indexed citations
7.
Stick, Stephen M., Robert S. Ware, Harm A.W.M. Tiddens, et al.. (2021). The Effect of Azithromycin on Structural Lung Disease in Infants with Cystic Fibrosis (COMBAT CF): A Phase 3, Randomised, Double-Blind, Placebo-Controlled Clinical Trial. SSRN Electronic Journal. 2 indexed citations
8.
Mikkelsen, Helga, William Ditcham, David W. Reid, et al.. (2020). Role of Tris-CaEDTA as an adjuvant with nebulised tobramycin in cystic fibrosis patients with Pseudomonas aeruginosa lung infections: A randomised controlled trial. Journal of Cystic Fibrosis. 20(2). 316–323. 5 indexed citations
9.
Eckersley, Luke, et al.. (2015). Exercise-induced hypoxia secondary to an atrial septal defect and cor triatriatum dexter. Cardiology in the Young. 26(4). 793–795. 3 indexed citations
10.
Clements, Barry, et al.. (2010). Long-Term Results of Percutaneous Transhepatic Cholangiographic Drainage for Palliation of Malignant Biliary Obstruction. Journal of Palliative Medicine. 13(11). 1311–1313. 25 indexed citations
11.
Douglas, Tonia, S. Brennan, Catherine Gangell, et al.. (2008). Acquisition and eradication ofP. aeruginosain young children with cystic fibrosis. European Respiratory Journal. 33(2). 305–311. 131 indexed citations
13.
Chaney, Gervase, Barry Clements, Lou I. Landau, Max Bulsara, & Paul M. Watt. (2004). A new asthma spacer device to improve compliance in children: a pilot study. Respirology. 9(4). 499–506. 12 indexed citations
14.
Sidhu, Stan B., T F Lioe, & Barry Clements. (2000). Thyroid papillary carcinoma in lateral neck cyst: missed primary tumour or ectopic thyroid carcinoma within a branchial cyst?. The Journal of Laryngology & Otology. 114(9). 716–718. 35 indexed citations
16.
Clements, Barry, et al.. (1995). A Late, Fatal Complication of a High Energy Thermal Injury to the Scalp. Annals of Plastic Surgery. 35(6). 650–653. 13 indexed citations
17.
Cutler, N.R., et al.. (1995). Oral sumatriptan for the acute treatment of migraine: evaluation of three dosage strengths.. PubMed. 45(8 Suppl 7). S5–9. 54 indexed citations
19.
Clements, Barry, J O Warner, & E A Shinebourne. (1987). Congenital bronchopulmonary vascular malformations: clinical application of a simple anatomical approach in 25 cases.. Thorax. 42(6). 409–416. 30 indexed citations
20.
Gjerde, C L, William M. Clements, & Barry Clements. (1982). Publication characteristics of family practice faculty nominated for academic promotion.. PubMed. 15(4). 663–6. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026